BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients
Patients with cystic fibrosis (CF) colonized with Pseudomonas aeruginosa (P. aeruginosa) have worse prognosis compared with patients who are not. BPI-ANCA is an anti-neutrophil cytoplasmic antibody against BPI (bactericidal/permeability increasing protein) correlating with P. aeruginosa colonization...
Saved in:
Main Authors: | Ulrika Lindberg, Malin Carlsson, Thomas Hellmark, Mårten Segelmark |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/947934 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pseudomonas cepacia in cystic fibrosis
by: Ronald Gold
Published: (1993-01-01) -
Epidemiology of Pseudomonas cepacia in Cystic Fibrosis
by: Statement from the Medical/Scientific Advisory Committee Canadian Cystic Fibrosis Foundation
Published: (1993-01-01) -
Hepatic Abscess due to Burkholderia (Pseudomonas) cepacia in Cystic Fibrosis
by: Kristin L Fraser, et al.
Published: (1995-01-01) -
Treatment of Pseudomonas and Staphylococcus Bronchopulmonary Infection in Patients with Cystic Fibrosis
by: Rashmi Ranjan Das, et al.
Published: (2013-01-01) -
Pseudomonas Aeruginosa and Cystic Fibrosis: Antibiotic Therapy and the Science behind the Magic
by: Noni E MacDonald
Published: (1997-01-01)